Who is sponsoring NCT04712292?

NCT04712292 is sponsored by University of Bologna.

What drugs are being tested in NCT04712292?

Interventions in NCT04712292: Surgical procedure for confirmed or suspected colorectal cancer.

What condition does NCT04712292 study?

NCT04712292 studies Colorectal Neoplasms Malignant.

Is NCT04712292 still recruiting?

NCT04712292 is currently status unknown. Last updated 28 February 2022.

Last reviewed 2022-02-28 · How we verify

NCT04712292: COVID-CRC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of COVID-19 Pandemic on the Outcomes of Colorectal Cancer

Status unknown Last updated 28 February 2022

What this trial tests

trial testing Surgical procedure for confirmed or suspected colorectal cancer in Colorectal Neoplasms Malignant in 15,000 participants. Status unknown.

Timeline

8 September 2020

Primary endpoint
15 February 2022

1 April 2022

Quick facts

Lead sponsor	University of Bologna
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	15,000
Start date	8 September 2020
Primary completion	15 February 2022
Estimated completion	1 April 2022
Sites	45 locations across Italy

Drugs / interventions tested

Surgical procedure for confirmed or suspected colorectal cancer

Conditions studied

Colorectal Neoplasms Malignant — all drugs for Colorectal Neoplasms Malignant →

Sponsor

University of Bologna

Who can join

Eligibility, any sex, with Colorectal Neoplasms Malignant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been identified as the cause of the Coronavirus disease 19 (COVID-19), which was initially reported in December 2019 in China and has since rapidly spread worldwide. Since then, the COVID-19 pandemic has caused a detrimental effect of the national health care system, causing a drastic reduction of the screening programs for colorectal cancer and requiring the redistribution of the hospital resources from elective surgery to the care of patients with SARS-Cov\_2 infection requiring admission.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy.
Rottoli M, Gori A, Pellino G, Flacco ME, et al · · 2022 · cited 57× · PMID 36409496 · DOI 10.1001/jamanetworkopen.2022.43119
Impact of COVID-19 on the oncological outcomes of colorectal cancer surgery in northern Italy in 2019 and 2020: multicentre comparative cohort study.
Rottoli M, Pellino G, Spinelli A, Flacco ME, et al · · 2022 · cited 29× · PMID 35143629 · DOI 10.1093/bjsopen/zrab139
Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study.
Rottoli M, Spinelli A, Pellino G, Gori A, et al · · 2024 · cited 9× · PMID 37963162 · DOI 10.1093/bjs/znad373
The impact of COVID-19 on the oncologic outcomes of 3236 patients undergoing ColoRectal Cancer surgery in Northern Italy in 2019 and 2020 (COVID-CRC): results of a multicentric comparative cohort study
Rottoli M, Pellino G, Spinelli A, Flacco ME, et al · · 2021 · cited 1× · DOI 10.1101/2021.04.19.21255730

Verify or expand the search:

Other recruiting trials for Colorectal Neoplasms Malignant

Currently open trials in the same condition.

NCT06989814 — Smart Measurement of Circulating Tumor DNA · NA · recruiting
NCT06643793 — Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC · Phase 2 · recruiting
NCT06714903 — Effect of Gut Microbiota and Its Metabolites on the Efficacy of Immunotherapy in Metastatic Colorectal Cancer · recruiting
NCT06778382 — Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease · Phase 2 · recruiting
NCT06200831 — Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases · NA · recruiting

Other University of Bologna trials

Trials by the same sponsor.

NCT07431047 — Fast-Track Protocol for Endovascular Aneurysm Repair (EVAR) of Infrarenal Abdominal Aortic Aneurysms · not yet recruiting
NCT07295197 — Oral Indicators for ED Screening · recruiting
NCT07198789 — Randomized, Double-blind Crossover Trial Comparing Low-GI Functional vs. Standard Wholegrain Carbohydrates on Glycolipid · NA · not yet recruiting
NCT07127796 — Non-inferiority RCT on Fish Waste-Derived vs. Synthetic Vitamin D Supplementation in Healthy Adults With Suboptimal Vita · NA · not yet recruiting
NCT07041060 — Evaluation of the Efficacy and Safety of Eolo in Patients With NERD · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04712292 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Bologna
Last refreshed: 28 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04712292.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing